We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+17.36%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.98B
AUM Growth
+$266M
Cap. Flow
+$123M
Cap. Flow %
6.23%
Top 10 Hldgs %
54.68%
Holding
148
New
19
Increased
38
Reduced
28
Closed
8

Top Buys

Rank Stock Value
1
FULC icon
Fulcrum Therapeutics
FULC
+$35.4M
2
TITN icon
Titan Machinery
TITN
+$24.4M
3
BKSY icon
BlackSky Technology
BKSY
+$19.4M
4
CRMT icon
America's Car Mart
CRMT
+$13.5M
5
PWSC
PowerSchool Holdings, Inc.
PWSC
+$13.2M

Top Sells

Rank Stock Value
1
CASH icon
Pathward Financial
CASH
+$17.8M
2
IMAX icon
IMAX
IMAX
+$10.2M
3
BVS icon
Bioventus
BVS
+$8.54M
4
ESTA icon
Establishment Labs
ESTA
+$6.68M
5
RDNW
RideNow Group
RDNW
+$5.58M

Sector Composition

Rank Sector Weight
1 Healthcare 41.22%
2 Consumer Discretionary 6.49%
3 Communication Services 3.21%
4 Financials 3.01%
5 Industrials 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDNW
51
CALL
RideNow Group
RDNW
$248M
$8.14M 0.41%
+1,700,000
New +$7.02M
EHTH icon
52
eHealth
EHTH
$40.4M
$7.8M 0.39%
1,911,821
– –
BNTC icon
53
Benitec Biopharma
BNTC
$473M
$7.7M 0.39%
838,095
-3,300
-0.4% -$29.5K
MLYS icon
54
Mineralys Therapeutics
MLYS
$2.41B
$7.66M 0.39%
632,506
+100,000
+19% +$1.21M
GPCR icon
55
Structure Therapeutics
GPCR
$3.82B
$7.51M 0.38%
+171,000
New +$6.61M
VNDA icon
56
Vanda Pharmaceuticals
VNDA
$304M
$7.47M 0.38%
1,593,516
– –
XTNT icon
57
Xtant Medical Holdings
XTNT
$62.6M
$7.44M 0.38%
11,394,000
+7,814,000
+218% +$5.17M
ATXS
58
DELISTED
Astria Therapeutics
ATXS
$7.43M 0.38%
675,000
– –
IRON icon
59
Disc Medicine
IRON
$3.01B
$7.37M 0.37%
150,000
– –
IMTX icon
60
Immatics
IMTX
$1.33B
$7.14M 0.36%
625,659
-162,315
-21% -$1.92M
STKS icon
61
The ONE Group
STKS
$56.5M
$6.2M 0.31%
1,684,073
+481,545
+40% +$1.94M
OCUL icon
62
Ocular Therapeutix
OCUL
$2.03B
$6.09M 0.31%
700,000
-300,000
-30% -$2.47M
ETON icon
63
Eton Pharmaceutcials
ETON
$1.2B
$5.99M 0.3%
998,733
+58,000
+6% +$245K
NSPR icon
64
InspireMD
NSPR
$37.5M
$5.92M 0.3%
2,209,593
+182,993
+9% +$499K
CLRB icon
65
Cellectar Biosciences
CLRB
$20.8M
$5.8M 0.29%
90,415
+29,304
+48% +$1.93M
HLF icon
66
CALL
Herbalife
HLF
$1.21B
$5.75M 0.29%
800,000
– –
ALTG icon
67
Alta Equipment Group
ALTG
$237M
$5.7M 0.29%
845,115
+6,893
+0.8% +$53K
NNBR icon
68
NN Inc
NNBR
$300M
$5.69M 0.29%
1,458,416
+1,970
+0.1% +$7.1K
NDLS icon
69
Noodles & Co
NDLS
$96M
$5.41M 0.27%
563,541
+25,000
+5% +$303K
ILPT
70
Industrial Logistics Properties Trust
ILPT
$583M
$5.38M 0.27%
1,131,132
-738,821
-40% -$3.47M
LXFR icon
71
Luxfer Holdings
LXFR
$457M
$5.36M 0.27%
413,950
-190,193
-31% -$2.21M
NKTR icon
72
Nektar Therapeutics
NKTR
$2.53B
$5.34M 0.27%
274,000
– –
RDI icon
73
Reading International Class A
RDI
$35.2M
$5.28M 0.27%
3,236,497
-8,076
-0.2% -$12.6K
TELA icon
74
TELA Bio
TELA
$41.6M
$4.85M 0.25%
1,915,126
-530,541
-22% -$1.89M
VTGN icon
75
VistaGen Therapeutics
VTGN
$11.7M
$4.57M 0.23%
1,517,696
– –
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Nantahala Capital Management held 148 positions worth $1.98B, up 16% from $1.71B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Nantahala Capital Management deployed $123M of net new capital in Q3 2024, opening 19 new positions and adding to 38 existing holdings. Its largest new stake was Fulcrum Therapeutics: 4,777,912 shares worth $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Pathward Financial, an estimated $17.8M trimmed.

  • Nantahala Capital Management's largest Q3 2024 buy was Fulcrum Therapeutics: 4,777,912 shares worth $17.1M.
  • Nantahala Capital Management added most to America's Car Mart in Q3 2024, an estimated $13.5M increase.
  • Nantahala Capital Management's biggest Q3 2024 reduction was Pathward Financial, cutting an estimated $17.8M.
  • Nantahala Capital Management fully exited Avadel Pharmaceuticals in Q3 2024, selling an estimated $4.92M.
  • Nantahala Capital Management's ten largest holdings make up 55% of its $1.98B portfolio in Q3 2024.
  • Nantahala Capital Management opened 19 new positions and closed 8 in Q3 2024.
  • Nantahala Capital Management's portfolio value rose 16% quarter-over-quarter to $1.98B.

Based on Nantahala Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.